Skip to main content
. 2019 Dec 18;2019:9251879. doi: 10.1155/2019/9251879

Table 2.

H. pylori eradication rates of each group in PP and ITT analysis.

Population Eradication by group (%) p
RMAB RMMB RACB
Rate n/N (%) 95% CI Rate n/N (%) 95% CI Rate n/N (%) 95% CI
ITT 102/119 (85.7) 79.3~92.1 91/118 (77.1) 69.4~84.8 86/120 (71.7) 63.5~79.8 0.030
PP 102/114 (89.5) 83.8~95.2 91/108 (84.3) 77.3~91.2 86/112 (76.8) 68.8~84.7 0.036∗∗

p = 0.008, RMAB vs. RACB; p = 0.089, RMAB vs. RMMB; p = 0.335, RMMB vs. RACB. ∗∗p = 0.011, RMAB vs. RACB; ∗∗p = 0.250, RMAB vs. RMMB; ∗∗p = 0.163, RMMB vs. RACB. RMAB group: rabeprazole plus minocycline, amoxicillin, and bismuth; RMMB group: rabeprazole plus minocycline, metronidazole, and bismuth; RACB group: rabeprazole plus amoxicillin, clarithromycin, and bismuth. ITT: intention-to-treatment; PP: per-protocol; CI: confidence interval.